#statinsHD #statinsmuscleHD #statinsliverHD #statinsdiabetesHD
Genetics suggest statins' small diabetes risk is tied to LDL lowering (Gemini-assisted)
Louis shares a post, written with Gemini AI, arguing that the small rise in new-onset type 2 diabetes with intensive lipid lowering reflects target-mediated effects rather than an off-target drug side effect. Genetic variants mimicking HMGCR (statin) and NPC1L1 (ezetimibe) inhibition show modestly higher glucose and diabetes risk.




